Key result
Non-hospitalised patients with long COVID demonstrated a significantly elevated hypoxic ventilatory response (-0.44 vs -0.17 L/min/SpO2%) compared to healthy controls.
Why the study?
The mechanisms underlying long COVID symptoms like breathlessness and exercise intolerance are unknown, and whether carotid chemoreflex sensitivity is elevated remained to be investigated.
Case-Control (n=28)
No
Carotid chemoreflex sensitivity is elevated in long COVID patients and correlates with excessive hyperventilation during exercise, suggesting a potential mechanism and therapeutic target for dysregulated breathing and exercise intolerance.
Answers are grounded in this paper and cite their sources.
May suggest chemoreflex-targeted therapies for long COVID symptoms; leaves open causal role pending prospective trials.
The symptoms of long COVID, which include fatigue, breathlessness, dysregulated breathing, and exercise intolerance, have unknown mechanisms. These symptoms are also observed in heart failure and are partially driven by increased sensitivity of the carotid chemoreflex. As the carotid body has an abundance of ACE2 (the cell entry mechanism for SARS-CoV-2), we investigated whether carotid chemoreflex sensitivity was elevated in participants with long COVID. During cardiopulmonary exercise testing, the V E /VCO 2 slope (a measure of breathing efficiency) was higher in the long COVID group than in the controls, indicating excessive hyperventilation. The hypoxic ventilatory response, which measures carotid chemoreflex sensitivity, was increased in long COVID participants and correlated with the V E /VCO 2 slope, suggesting that excessive hyperventilation may be related to carotid body hypersensitivity. Therefore, the carotid chemoreflex is sensitized in long COVID and may explain dysregulated breathing and exercise intolerance in these participants. Tempering carotid body excitability may be a viable treatment option for long COVID patients.
No takes yet. Share an insight, caveat, or question.
El‐Medany et al. (2023) conducted a case-control in Long COVID (n=28). Long COVID vs. Healthy controls was evaluated on Hypoxic ventilatory response (minute ventilation response to reductions in SpO2%) (p=0.0007). Non-hospitalised patients with long COVID demonstrated a significantly elevated hypoxic ventilatory response (-0.44 vs -0.17 L/min/SpO2%) compared to healthy controls.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: